Health product recall

Docetaxel Injection USP (2019-10-04)

Starting date:
October 4, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-71235

Last updated: 2019-10-08

Summary

  • Product: Docetaxel Injection USP 10 mg/mL

Reason

The impurity 10-oxo-docetaxel could be out-of-specification in the affected lots.

Depth of distribution

Healthcare establishments

Affected products

Docetaxel Injection USP 10 mg/mL

DIN, NPN, DIN-HIM

DIN 02361957

Dosage form

Solution

Strength

Docetaxel 10 mg/mL

Lot or serial number

DC31807A

Companies

Recalling Firm
Pfizer Canada ULC
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA
Marketing Authorization Holder
Pfizer Canada ULC
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: